Linezolid in Combination With Azoles Induced Synergistic Effects Against and Protected Against Experimental Candidiasis.

The incidence of resistant isolates has increased continuously in recent decades, especially . To overcome this resistance, research on antifungal sensitizers has attracted considerable attention. Linezolid was found to inhibit the growth of and synergize with amphotericin B against . The objective of this study was to determine the interactions of linezolid and azoles against and . , linezolid combined with azoles induced synergistic effects not only against some susceptible isolates, but also against all tested resistant isolates. For all resistant isolates, exposure to the combination of linezolid with azoles induced a significant decrease in the minimum inhibitory concentrations (MIC) of azoles, from >512 to 0.5-1 μg/mL for fluconazole, from >16 to 0.25-1 μg/mL for itraconazole, and from >16 to 0.03-0.25 μg/mL for voriconazole. Additionally, linezolid synergized with fluconazole against biofilms that were preformed for ≤ 12 h from both susceptible and resistant , and the sessile MIC of fluconazole decreased from >1024 to 1-4 μg/mL. , linezolid plus azoles prolonged the survival rate of infected larvae twofold compared with the azole monotherapy group, significantly decreased the fungal burden of the infected larvae, and reduced the damage of resistant to the larval tissue. These findings will contribute to antifungal agent discovery and new approaches for the treatment of candidiasis caused by .